HappeningToo topic
Risankizumab-rzaa reports
Browse community reports connected to Risankizumab-rzaa. These reports can show that other people are describing similar experiences, but they do not prove that Risankizumab-rzaa caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
31 problems
Abdominal Distension while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and abdominal distension appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and abdominal pain upper appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and abdominal pain appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and alopecia appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and anxiety appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and back pain appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and chills appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and constipation appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and cough appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and decreased appetite appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and dehydration appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and diarrhea appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and dizziness appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and dry skin appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and fatigue appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and feeling abnormal appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and headache appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and hives appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and insomnia appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and itching appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and malaise appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and muscle spasms appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and nausea appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and pain appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and rash appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and shortness of breath appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and skin redness appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and vomiting appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and weakness appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and weight decreased appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Risankizumab-rzaa
FDA FAERS contains adverse-event reports in which Risankizumab-rzaa and weight increased appear together. This does not establish that Risankizumab-rzaa caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →